Press coverage about AmerisourceBergen (NYSE:ABC) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. AmerisourceBergen earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.8334321953615 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of AmerisourceBergen (NYSE ABC) traded down $1.53 during mid-day trading on Tuesday, reaching $85.89. The company’s stock had a trading volume of 1,906,139 shares, compared to its average volume of 1,797,717. The company has a debt-to-equity ratio of 1.83, a quick ratio of 0.48 and a current ratio of 0.91. AmerisourceBergen has a 12 month low of $71.90 and a 12 month high of $97.85. The firm has a market cap of $18,730.00, a price-to-earnings ratio of 14.42, a P/E/G ratio of 1.47 and a beta of 0.99.

AmerisourceBergen (NYSE:ABC) last issued its earnings results on Thursday, November 2nd. The company reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.32 by $0.01. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The company had revenue of $39.12 billion for the quarter, compared to analyst estimates of $40.10 billion. During the same period in the prior year, the firm posted $1.30 EPS. The business’s revenue was up 4.2% compared to the same quarter last year. sell-side analysts forecast that AmerisourceBergen will post 6.06 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, December 4th. Shareholders of record on Monday, November 20th were given a $0.38 dividend. This is a positive change from AmerisourceBergen’s previous quarterly dividend of $0.37. This represents a $1.52 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend was Friday, November 17th. AmerisourceBergen’s dividend payout ratio is presently 93.83%.

Several brokerages recently issued reports on ABC. Deutsche Bank began coverage on AmerisourceBergen in a research note on Monday. They issued a “buy” rating and a $97.00 price objective for the company. Robert W. Baird set a $99.00 price objective on AmerisourceBergen and gave the stock a “buy” rating in a research note on Friday. Needham & Company LLC increased their price objective on AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a research note on Wednesday, November 22nd. ValuEngine raised AmerisourceBergen from a “hold” rating to a “buy” rating in a research note on Tuesday, October 31st. Finally, Jefferies Group set a $85.00 price objective on AmerisourceBergen and gave the stock a “hold” rating in a research note on Sunday, October 29th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. AmerisourceBergen presently has an average rating of “Buy” and an average target price of $91.95.

In other news, Chairman Steven H. Collis sold 21,350 shares of the stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $76.94, for a total transaction of $1,642,669.00. Following the transaction, the chairman now owns 260,226 shares of the company’s stock, valued at approximately $20,021,788.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Tim G. Guttman sold 11,600 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $74.28, for a total value of $861,648.00. Following the transaction, the chief financial officer now directly owns 40,326 shares in the company, valued at approximately $2,995,415.28. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 165,407 shares of company stock worth $13,310,758. Insiders own 27.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://theolympiareport.com/2017/12/05/amerisourcebergen-abc-getting-somewhat-favorable-news-coverage-study-finds.html.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with Analyst Ratings Network's FREE daily email newsletter.